InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 14.00
-0.15 (-1.06%)
Mar 27, 2026, 9:00 AM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.52 billion as of March 26, 2026. Its market cap has decreased by -6.91% in one year.
Market Cap
1.52B
Enterprise Value
1.30B
Revenue
55.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.00
Market Cap Chart
Since September 13, 2012, InnoPharmax's market cap has decreased from 1.54B to 1.52B, a decrease of -1.27%. That is a compound annual growth rate of -0.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 1.52B | -15.77% |
| Dec 31, 2025 | 1.81B | 3.38% |
| Dec 31, 2024 | 1.75B | 5.76% |
| Dec 29, 2023 | 1.65B | 62.70% |
| Dec 30, 2022 | 1.02B | -32.67% |
| Dec 30, 2021 | 1.51B | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.97B |
| Tien Liang BioTech | 1.63B |
| GeneFerm Biotechnology | 1.54B |
| Winston Medical Supply | 1.30B |
| DV Biomed | 1.29B |
| Excelsior Biopharma | 1.28B |
| Anxo Pharmaceutical | 1.08B |
| Golden Biotechnology | 1.05B |